Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial

التفاصيل البيبلوغرافية
العنوان:	Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial
المؤلفون:	Pouyiourou, Maria^{Aff1, Aff2, Aff3}, Kraft, Bianca N.^{Aff1, Aff2}, Wohlfromm, Timothy, Stahl, Michael, Kubuschok, Boris, Löffler, Harald, Hacker, Ulrich T., Hübner, Gerdt, Weiss, Lena, Bitzer, Michael, Ernst, Thomas, Schütt, Philipp, Hielscher, Thomas, Delorme, Stefan, Kirchner, Martina^{Aff15, Aff16}, Kazdal, Daniel^{Aff15, Aff16}, Ball, Markus^{Aff15, Aff16}, Kluck, Klaus^{Aff15, Aff16}, Stenzinger, Albrecht^{Aff15, Aff16}, Bochtler, Tilmann^{Aff1, Aff2, Aff3}, Krämer, Alwin^{Aff1, Aff2, Aff3, IDs41467023424005_cor21}
المصدر:	Nature Communications. 14(1)
قاعدة البيانات:	Springer Nature Journals

كن أول من يترك تعليقا!